Baylor Researchers Contribute To OXiGENE’s Announcement of Patent for Benzosuberenes, a Novel Anticancer Class of Agents

The novel anti- cancer compounds KGP18 and KGP156 — the combined results of a collaboration between OXiGENE, Inc with Texas based researchers — has been issued Patent by US Patent and Trademark Office.

http://bionews-tx.com/news/2013/03/20/baylor-researchers-contribute-to-oxigenes-announcement-of-patent-for-benzosuberenes-a-novel-anticancer-class-of-agents/